RECITALSLicense and Supply Agreement • August 9th, 2007 • Critical Therapeutics Inc • Pharmaceutical preparations • Delaware
Exhibit 10.48 LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • April 3rd, 2006 • Amarillo Biosciences Inc • Pharmaceutical preparations • Texas
Exhibit 10.16 LICENSE AND SUPPLY AGREEMENT LICENSE AND SUPPLY AGREEMENT (this "Agreement") by and between PHARMACIA AB, a Delaware corporation ("Pharmacia"), and INSMED INCORPORATED, a Virginia corporation ("Insmed"), dated as of August 28, 2002 (the...License and Supply Agreement • March 28th, 2003 • Insmed Inc • Pharmaceutical preparations • New York
EXHIBIT 10.2 AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT THIS AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT (this "Agreement") is entered into and made effective as of this 1st day of January, 2005 (the "Restatement Date") by and between...License and Supply Agreement • March 7th, 2005 • GTX Inc /De/ • Pharmaceutical preparations
EXHIBIT 10.10 LICENSE AND SUPPLY AGREEMENT This Supply Agreement, dated as of the ninth day of February 2000, is between GENEVA PHARMACEUTICALS, INC., a Colorado corporation, with offices at 2655 West Midway Boulevard, Broomfield, Colorado 80038...License and Supply Agreement • January 31st, 2001 • Omp Inc • Pharmaceutical preparations • Colorado
AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENT (this “Amendment”) is entered into as of November 19, 2004, by and between PRONOVA BIOCARE A.S., a corporation incorporated under the laws of Norway (“Pronova”), located at Postboks 420, Vollsveien 6, NO-1327, Lysaker, Norway, and Reliant Pharmaceuticals, Inc., a Delaware corporation (“Reliant”), located at 110 Allen Road, Liberty Corner, New Jersey, 07938.
License and Supply AgreementLicense and Supply Agreement • April 29th, 2016 • Diadexus, Inc. • Pharmaceutical preparations • New York
This License and Supply Agreement (the “Agreement”) is made and entered into by and between diaDexus, Inc., located at 349 Oyster Point Boulevard, South San Francisco, CA 94080-1913 (hereinafter “Licensor”), and OriGene Technologies, Inc., located at 9620 Medical Center Dr., Suite 200, Rockville, MD 20850 (“OriGene”), and Wuxi OriGene Biotechnology Co., Ltd, a corporation organized under the laws of China located at No. 168, Meiliang RD, Mashan, Binhu District Wuxi City, Jiangsu Province, 214092 China, which is an Affiliate of OriGene (“WOBC”) (OriGene and WOBC are referred to herein collectively as “Licensee”), effective as of September 4, 2015, (the “Effective Date”). Licensor, OriGene and WOBC may be referred to herein individually as a “Party”, and collectively as the “Parties”.
AMENDMENT NO. 1 TO DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT Dated as of May 24, 2005 among ETHYPHARM, S.A. 92213 Saint Cloud France and RELIANT PHARMACEUTICALS, INC. Liberty Corner, New Jersey 07938 United StatesLicense and Supply Agreement • August 5th, 2005 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
AMENDMENT NO. 1 TO DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT (this “Amendment”) is hereby entered into as of May 24, 2005, by and among ETHYPHARM S.A., a corporation organized under the laws of France, with its principal offices at 194 Bureaux de la Colline, 92213 Saint Cloud, France (“ETHYPHARM”), and RELIANT PHARMACEUTICALS, INC., a corporation organized under the laws of the State of Delaware, with its principal offices at 110 Allen Road, Liberty Corner, New Jersey 07938, United States of America, and successor by conversion to Reliant Pharmaceuticals, LLC (“RELIANT”).
License and Supply Agreement By and Between Rani Therapeutics, LLC and Celltrion, Inc. Dated May 26, 2023License and Supply Agreement • August 11th, 2023 • Rani Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
This License and Supply Agreement (this “Agreement”), effective as of May 26, 2023 (the “Effective Date”), is by and between Rani Therapeutics, LLC, a California limited liability company having an address at 2051 Ringwood Ave., San Jose, California 95131, USA (“Rani”), and Celltrion, Inc., having an address at 23, Academy-ro, Yeonsu-gu, Incheon, 22014, Republic of Korea (“Celltrion”). Rani and Celltrion are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • April 26th, 2011 • Columbia Laboratories Inc • Pharmaceutical preparations
LICENSE AND SUPPLY AGREEMENT, dated as of March 11, 2011, between THE UROLOGY COMPANY LIMITED a company incorporated in England, with its registered office at 4th Floor, 233 High Holborn, London WC1V 7DN (“Urology Company”) and COLUMBIA LABORATORIES (BERMUDA), LTD., a Bermuda corporation, having its office at Canon's Court, 22 Victoria Street, PO Box HM 1179, Hamilton, HM EX Bermuda ("Columbia”)
License and Supply AgreementLicense and Supply Agreement • October 16th, 2013 • Ruthigen, Inc. • Pharmaceutical preparations • California
THIS LICENSE AND SUPPLY AGREEMENT (the “Agreement”) is executed as of the 23 day of May, 2013, shall become effective upon the closing of an IPO (as hereinafter defined) (the “Effective Date”), and is entered into by and between Ruthigen, Inc., a Nevada corporation (“Ruthigen”) and Oculus Innovative Sciences, Inc., a Delaware corporation (hereinafter referred to as “Oculus”). Oculus and Ruthigen are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. FIFTH AMENDMENT TO TRADEMARK...License and Supply Agreement • February 20th, 2024 • Travere Therapeutics, Inc. • Pharmaceutical preparations
This Fifth Amendment to Trademark License and Supply Agreement (“Fifth Amendment”), made effective September 30, 2020 (the “Fifth Amendment Effective Date”), amends the Trademark License and Supply Agreement dated May 28, 2014 by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”) (such agreement as previously amended by the amendments listed in Exhibit A to this Fifth Amendment, the “Agreement”).
AMENDMENT TO DEVELOPMENT, LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • March 29th, 2004 • Immunicon Corp • Laboratory analytical instruments • New York
This Amendment (the "Amendment") is made effective as of the 10th day of December, 2002 by and between ORTHO-CLINICAL DIAGNOSTICS, INC., a New York corporation ("OCD"), and IMMUNICON CORPORATION, a Delaware corporation, and its subsidiaries (collectively, "Immunicon"), to amend the Development, License and Supply Agreement by and between OCD and Immunicon dated as of August 17, 2000 (the "Agreement"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
Amended and Restated License and Supply AgreementLicense and Supply Agreement • July 6th, 2021 • Biofrontera Inc. • Pharmaceutical preparations • Delaware
This Amended and Restated License and Supply Agreement (the “Amendment”) is made effective as of June 16, 2021, by and between Biofrontera Pharma GmbH, a German corporation with its principal offices at Hemmelrather Weg 201, 51377 Leverkusen, Germany (“PHARMA”), Biofrontera Bioscience GmbH, a German corporation with its principal offices at Hemmelrather Weg 201, 51377 Leverkusen, Germany (“BIOSCIENCE”) and Biofrontera Inc., a Delaware corporation with its principal place of business at 120 Presidential Way, Suite 330, Woburn, MA 01801, USA (“INC”). PHARMA and INC may collectively be referred to as the “Original Parties.” PHARMA, BIOSCIENCE, and INC may collectively be referred to as the “Parties” or individually as a “Party.” Capitalized terms used but not defined herein shall have the meanings assigned to them in the LSA.
Amerinet Choice License & Supply AgreementLicense and Supply Agreement • September 26th, 2013 • Codesmart Holdings, Inc. • Food and kindred products • Missouri
This LICENSE & SUPPLY AGREEMENT is made and entered into as of the Commencement Date (defined below) by and among Amerinet, Inc. ("Amerinet"), Amerinet Choice, L.L.C. ("Amerinet Choice"), and The CODESMARTTM GROUP, Inc. ("Supplier").
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • July 29th, 2014 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • North Carolina
THIS LICENSE AND SUPPLY AGREEMENT ("Agreement") is by and between Oxygen Biotherapeutics, Inc., with a place of business at ONE Copley Parkway, Suite 490, Morrisville, North Carolina 27560 ("OBI" or "Licensor"), and Valor SA (Cosmetics Division), with a place of business at Boulevard de Grancy 1 – CH1006 Lausanne - Switzerland, ("VCD" or "Licensee"), (each individually referred to herein as a “Party” and collectively referred to as the “Parties”).
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 23rd, 2013 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This LICENSE AND SUPPLY AGREEMENT (“Agreement”) is entered into as of May 7, 2013 (the “Effective Date”) between ALEXZA PHARMACEUTICALS, INC., a company organized under the laws of the State of Delaware, United States (“Alexza”), and having a principal place of business at 2091 Stierlin Court, Mountain View, CA 94043, United States, and TEVA PHARMACEUTICALS USA, INC., a company organized under the laws of Delaware (“Teva”), having a principal place of business at 1090 Horsham Road, North Wales, PA 19454, United States.
LICENSE AND SUPPLY AGREEMENT effective as of the 23rd day of April, 2007 ("Effective Date") is entered into between PERKINELMER LAS, INC. Having a principal place of business at 940 Winter Street, Waltham, MA 02451 (hereinafter "PE") and HELICOS...License and Supply Agreement • May 21st, 2007 • Helicos Biosciences Corp • Pharmaceutical preparations • Massachusetts
PE is the owner of the entire right, title and interest in and to the Licensed Patents, as defined below, and Helicos desires a license under the Licensed Patents in the Field. PE is willing to grant such a license under the following terms and conditions.
BIOSEARCH ITALIA, S.P.A. AND GENOME THERAPEUTICS CORPORATIONLicense and Supply Agreement • November 12th, 2002 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • New York
LICENSE and SUPPLY AGREEMENT By and Between Immunicon Corporation And Research and Diagnostic Systems, Inc.License and Supply Agreement • March 29th, 2004 • Immunicon Corp • Laboratory analytical instruments • Delaware
THIS LICENSE and SUPPLY AGREEMENT (hereinafter "Agreement"), dated and effective as of the Effective Date (as hereinafter defined) on behalf of each of the parties hereto and their Affiliates (as hereinafter defined), is by and between Immunicon Corporation, a corporation organized and existing under the laws of the state of Delaware, having an office at 3401 Masons Mill, Suite 100, Huntingdon Valley, Pennsylvania 19006, together with its Affiliates (hereinafter collectively, "Immunicon"), and Research and Diagnostic Systems, Inc., a corporation organized and existing under the laws of the state of Minnesota, having an office at 614 McKinley Place N.E., Minneapolis, Minnesota 55413, together with its Affiliates (hereinafter collectively, "RDS").
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • April 13th, 2012 • Rib-X Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WHEREAS, CyDex is engaged in the business of developing and commercializing novel drug delivery technologies designed to enhance the solubility and effectiveness of existing and development-stage drugs;
CONFIDENTIAL TREATMENT REQUESTED LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • January 6th, 2014 • Aldexa Therapeutics, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, CyDex is engaged in the business of developing and commercializing novel drug delivery technologies designed to enhance the solubility and effectiveness of existing and development-stage drugs;
LICENSE AND SUPPLY AGREEMENT By and Between Velodyne LiDAR, Inc. AND Veoneer US, Inc.License and Supply Agreement • October 5th, 2020 • Velodyne Lidar, Inc. • General industrial machinery & equipment, nec • New York
This License and Supply Agreement (hereinafter, the “Agreement”) is entered into on the date that Velodyne LiDAR, Inc. receives from Veoneer US, Inc. a binding purchase order for $[*] USD for the transfer of documents as set forth in Section 3.7 of this Agreement (provided that Velodyne LiDAR, Inc. receives such purchase order prior to March 1, 2019) (hereinafter, the “Effective Date”) by and between:
Portions of the exhibit marked [*] are requested to be treated confidentially. Dated 7 December 2005 Norgine B.V. – and – Salix Pharmaceuticals, Inc. LICENSE AND SUPPLY AGREEMENT CityPoint, One Ropemaker Street | London EC2Y 9AW Tel: +44 20 7920 4000...License and Supply Agreement • March 26th, 2009 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • England and Wales
SECOND AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • May 18th, 2010 • Columbia Laboratories Inc • Pharmaceutical preparations • New York
This Second Amended and Restated License and Supply Agreement (the "Agreement") made and entered into as of this 14th day of May, 2010, effective as of May 19, 2010 (the “Second A&R Agreement Date”), by and between Columbia Laboratories (Bermuda) Limited, a Bermuda corporation having its principal place of business at Canon’s Court, 22 Victoria Street, PO Box HM 1179, Hamilton HM 12, Bermuda ("Licensor"), and Ares Trading S.A., a Swiss company with its principal place of business at c/o Zone Industrielle , 1267 Coinsins, Switzerland ("Licensee").
LICENSE AND SUPPLY AGREEMENT BY AND BETWEEN DR. REDDY'S LABORATORIES LTD. AND JOURNEY MEDICAL CORPORATION DATED AS OF JULY 29, 2020 LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 22nd, 2021 • Journey Medical Corp • Pharmaceutical preparations • New York
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • May 16th, 2012 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • February 17th, 2004 • Xcyte Therapies Inc • Pharmaceutical preparations • Washington
This License and Supply Agreement (“Agreement”) is entered into as of October 15th, 1999 (the “Effective Date”) by and between Xcyte Therapies, Inc., a Delaware corporation having a principal place of business at 2203 Airport Way South, Suite 300, Seattle, Washington 98134, United States (“Xcyte”), and Diaclone S.A., a French corporation having a principal place of business at 1 Boulevard Fleming, B.P. 1985 F-25020 Besancon Cedex, France (“Diaclone”).
License and Supply AgreementLicense and Supply Agreement • September 24th, 2013 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
THIS LICENSE AND SUPPLY AGREEMENT (the “Agreement”) is executed as of the 23 day of May, 2013, shall become effective upon the closing of an IPO (as hereinafter defined) (the “Effective Date”), and is entered into by and between Ruthigen, Inc., a Nevada corporation (“Ruthigen”) and Oculus Innovative Sciences, Inc., a Delaware corporation (hereinafter referred to as “Oculus”). Oculus and Ruthigen are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • June 22nd, 2006 • Jazz Semiconductor Inc • Semiconductors & related devices • California
THIS AGREEMENT, is made and entered into this 16th day of December, 2003 (“Effective Date”) by and between NEWPORT FAB, LLC, a Delaware limited liability company d/b/a Jazz Semiconductor (“Jazz”), and ADVANCE SEMICONDUCTOR MANUFACTURING CORP. OF SHANGHAI, a corporation formed under the laws of the Peoples Republic of China (“ASMC”) (hereinafter Jazz and ASMC may each be referred to as a “party” and may be jointly referred to as “parties”).
DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT Dated as of January 27, 2000 between EURAND AMERICA, NC. Vandalia, Ohio 45377 and RELIANT PHARMACEUTICALS New York, NY 10019 for EXTENDED RELEASE PROPRANOLOLLicense and Supply Agreement • August 5th, 2005 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT, dated as of January 27, 2000, between EURAND AMERICA, INC., a corporation organized under the laws of Nevada, with its principal offices at 845 Center Drive, Vandalia, Ohio 45377 (“EURAND”), and RELIANT PHARMACEUTICALS, INC., a corporation organized under the laws of the State of Delaware, with its principal offices at 125 West 55th Street, 11th floor, New York, New York (“RELIANT”);
LICENSE AND SUPPLY AGREEMENT BY AND BETWEEN GLYCOSYN, LLC AND LUPA BIO, INC.License and Supply Agreement • April 8th, 2022 • Intrinsic Medicine, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS EXCLUSIVE LICENSE, CLINICAL SUPPLY AND PARTNERSHIP AGREEMENT (the “Agreement”) made and entered into as of July 30, 2020 (the “Effective Date”), by and between GLYCOSYN LLC (“Glycosyn”) at 890 Winter Street, Suite 208, Waltham, MA 02451 and LUPA BIO, INC. (“Lupa Bio”) at [***], Glycosyn and Lupa Bio are hereinafter referred to individually as a “Party” and jointly as “Parties.”
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH “[***]. LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 22nd, 2021 • Journey Medical Corp • Pharmaceutical preparations • Delaware
This License and Supply Agreement ("Agreement"), dated as of March 10, 2015 (the "Effective Date"), is made by and between Journey Medical Corporation, a Delaware corporation ("Journey"), and Blu Caribe, Inc., a Puerto Rican corporation ("Blu").
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.License and Supply Agreement • February 4th, 2021 • Lannett Co Inc • Pharmaceutical preparations • New York
This LICENSE AND SUPPLY AGREEMENT (“Agreement”), effective as of January 1, 2014 (the “Effective Date”) is by and between ALKERMES PHARMA IRELAND LIMITED, a limited liability company incorporated under the laws of Ireland (“Alkermes”). and KREMERS URBAN PHARMACEUTICALS INC., an Indiana corporation (“KU”).
EXHIBIT 10.2 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED BY MARKING SUCH PORTIONS WITH ASTERISKS (THE "MARK"). THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION WITHOUT THE MARK PURSUANT TO THE COMPANY'S...License and Supply Agreement • May 14th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • California
